Charles River Laboratories International (CRL) Cash from Financing Activities (2009 - 2025)

Charles River Laboratories International (CRL) has reported Cash from Financing Activities for 17 consecutive years, with -$51.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 31.65% year-over-year to -$51.9 million; the TTM figure through Dec 2025 stood at -$536.7 million (up 2.58% YoY), while the FY2025 annual figure was -$536.7 million, up 2.58% from the prior year.
• Cash from Financing Activities came in at -$51.9 million for Q4 2025 at Charles River Laboratories International, up from -$152.6 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $518.0 million in Q2 2021, with the low at -$285.9 million in Q2 2024.
• Average Cash from Financing Activities over 5 years is -$27.1 million, with a median of -$61.7 million recorded in 2023.
• Across the five-year window, Cash from Financing Activities soared 597.57% in 2021 and plunged 674.1% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at -$219.0 million in 2021, then dropped by 13.69% to -$249.0 million in 2022, then jumped by 149.63% to $123.6 million in 2023, then plunged by 161.41% to -$75.9 million in 2024, then soared by 31.65% to -$51.9 million in 2025.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$51.9 million, -$152.6 million, and -$226.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.